ArticleMolecular therapy. Methods & clinical development2025
Orthogonal approaches to AAV vector characterization: Validating quantitative TEM for partially filled particles.
Article in Molecular therapy. Methods & clinical development, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Reactive species generated by a cold atmospheric plasma inactivate AAV through oxidative and nitrosative stress.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adeno-associated viruses (AAVs) have emerged as a leading vector for gene therapy due to their non-pathogenic nature and ability to deliver therapeutic genes effectively. However, the presence of empty and partially filled capsids in AAV preparations can significantly impact therapeutic efficacy, and therefore, robust quality control methods for accurate characterization are required. This study presents quantitative electron microscopy (QuTEM) as a platform-validated method for distinguishing full, partial, and empty AAV capsids based on their internal density. We compared this enhanced TEM method with analytical ultracentrifugation (AUC), mass photometry (MP), and SEC-HPLC (size exclusion chromatography-high-performance liquid chromatography), to assess their effectiveness in characterizing AAV vector content. AAV vectors were produced using both self-complementary (scAAV) and single-stranded (ssAAV) transgenes, and their encapsidation efficiency was evaluated. Results demonstrated that QuTEM provided a reliable quantification of AAV populations, yielding a high concordance with MP and AUC data. Notably, QuTEM exhibited superior granularity by directly visualizing the viral capsids in their native state, preserving structural integrity. These features position the QuTEM analytical method as a potential gold standard for AAV characterization. Additionally, these findings emphasize the importance of integrated analytical approaches in optimizing AAV production and characterization, ensuring its consistency and efficacy for gene therapy applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.